An Update on Human Stem Cell-Based Therapy in Parkinson's Disease
Clara González, Sonia Bonilla, Ana Isabel Flores
1Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas. Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain.
Current Stem Cell Research & Therapy
|June 2, 2015
Summary
Parkinson's disease (PD) treatment shows promise with stem cell therapy, offering potential for cell replacement and symptom improvement. Research reviews current clinical studies and stem cell types for PD therapy.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder causing dopaminergic neuron loss.
- Current treatments for PD are symptomatic, lacking a cure.
- Stem cell technology offers a promising therapeutic avenue for PD.
Purpose of the Study:
- To review recent clinical studies on stem cell-based therapy for Parkinson's disease.
- To provide an overview of available stem cell types, their properties, and therapeutic potential for PD.
Main Methods:
- Review of current and recent clinical studies on stem cell therapy for PD.
- Analysis of different stem cell types and their characteristics relevant to PD treatment.
Main Results:
- Fetal cell transplantation demonstrated proof of concept for cell replacement therapy in PD.
- Stem cell therapies can act via cell replacement, trophic support, and immunomodulation.
- Ethical and practical limitations exist for fetal-derived cell transplantation.
Conclusions:
- Stem cell-based therapies hold significant potential for treating Parkinson's disease.
- Exploring diverse stem cell sources is crucial for advancing PD treatment.
- Continued research and clinical studies are vital for realizing the therapeutic benefits of stem cells in PD.
Related Concept Videos
EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Induced Pluripotent Stem Cells
28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells
6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.3K


